» Articles » PMID: 31541354

Differential Effects of Membrane Sphingomyelin and Cholesterol on Agonist-induced Bitter Taste Receptor T2R14 Signaling

Overview
Publisher Springer
Specialty Biochemistry
Date 2019 Sep 22
PMID 31541354
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Membrane lipids regulate the structure and function of G protein-coupled receptors (GPCRs). Previously we have shown that membrane cholesterol regulates the signaling of two human bitter taste receptors (T2Rs), T2R4 and T2R14. Another major plasma membrane lipid known to influence the function of membrane proteins including GPCRs is sphingomyelin. The role of sphingomyelin in T2R function is unexplored thus far. In this work, we examined the significance of sphingomyelin in T2R14 signaling. Results suggest that unavailability of membrane sphingomyelin did not affect the agonist-promoted T2R14 Ca signaling in heterologous expression system and also in primary airway smooth muscle cells (HASM cells). In addition, T2R14 mediated downstream AMPK activation was also unaffected in sphingomyelin-depleted condition; however, cholesterol depletion impaired the T2R14-mediated AMPK activation. Angiotensin II type1A receptor (ATR) expressed in HASM cells and signals through Ca and AMPK was used as a control. Results suggest that similar to T2R14, membrane sphingomyelin depletion did not affect ATR signaling. However, membrane cholesterol depletion impaired ATR mediated Ca signaling and AMPK activation. Interestingly, amino acid sequence analysis revealed the presence of putative sphingolipid binding motif in both T2R14 and ATR suggesting that the presence of a motif alone might not be suggestive of sphingomyelin sensitivity. In conclusion, these results demonstrate that in contrast to membrane cholesterol, sphingomyelin does not affect the agonist-induced T2R14 signaling, however it may play a role in other aspects of T2R14 function.

Citing Articles

Insights into the Role of Membrane Lipids in the Structure, Function and Regulation of Integral Membrane Proteins.

Renard K, Byrne B Int J Mol Sci. 2021; 22(16).

PMID: 34445730 PMC: 8396450. DOI: 10.3390/ijms22169026.

References
1.
Goni F, Alonso A . Sphingomyelinases: enzymology and membrane activity. FEBS Lett. 2002; 531(1):38-46. DOI: 10.1016/s0014-5793(02)03482-8. View

2.
Ikeda M, Arai M, Okuno T, Shimizu T . TMPDB: a database of experimentally-characterized transmembrane topologies. Nucleic Acids Res. 2003; 31(1):406-9. PMC: 165467. DOI: 10.1093/nar/gkg020. View

3.
Chattopadhyay A, Paila Y, Shrivastava S, Tiwari S, Singh P, Fantini J . Sphingolipid-binding domain in the serotonin(1A) receptor. Adv Exp Med Biol. 2012; 749:279-93. DOI: 10.1007/978-1-4614-3381-1_19. View

4.
Harikumar K, Puri V, Singh R, Hanada K, Pagano R, Miller L . Differential effects of modification of membrane cholesterol and sphingolipids on the conformation, function, and trafficking of the G protein-coupled cholecystokinin receptor. J Biol Chem. 2004; 280(3):2176-85. DOI: 10.1074/jbc.M410385200. View

5.
Chandrashekar J, Hoon M, Ryba N, Zuker C . The receptors and cells for mammalian taste. Nature. 2006; 444(7117):288-94. DOI: 10.1038/nature05401. View